Showing results (121-130 of 196) with videos related to
Sort By:
Pageof 20
BMC Surgery|May 9, 2024
Real-world efficacy of adjuvant therapy for totally resected stage I lung adenocarcinoma patients with pathological high-risk factors: propensity score analysisKe Zhao, Libing Yang, Lei Liu, et al.Imeta|October 21, 2024
Role of respiratory system microbiota in development of lung cancer and clinical applicationBowen Li, Daoyun Wang, Chengye Zhang, et al.Biology Direct|April 14, 2023
USP5 knockdown alleviates lung cancer progression via activating PARP1-mediated mTOR signaling pathwayLei Cao, Hongsheng Liu, Cheng Huang, et al.Thoracic Cancer|June 9, 2021
Pathological complete response to neoadjuvant ceritinib of a crizotinib-resistant, stage IIIB non-small cell lung cancer with ALK rearrangement: A case reportZhongxing Bing, Ziqi Jia, Yadong Wang, et al.Thoracic Cancer|February 2, 2026
Open-Label Randomized Controlled Study of a Disposable Dry Seal Chest Drainage System for Safety and Efficiency in Lobectomy PatientsLei Liu, Xuehan Gao, Jiaqi Zhang, et al.Cancers|October 14, 2022
Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Combination Therapy as First-Line Treatment for Patients with Advanced EGFR-Mutated, Non-Small Cell Lung Cancer: A Systematic Review and Bayesian Network Meta-AnalysisJianchao Xue, Bowen Li, Yadong Wang, et al.Journal of Surgical Oncology|October 30, 2016
Immunophenotypic and prognostic analysis of PAX8 and TTF-1 expressions in neuroendocrine carcinomas of thymic origin: A comparative study with their pulmonary counterpartsYalan Bi, Yinghui Deng, Shanqing Li, et al.Anesthesia and Analgesia|July 27, 2019
Two-Week Multimodal Prehabilitation Program Improves Perioperative Functional Capability in Patients Undergoing Thoracoscopic Lobectomy for Lung Cancer: A Randomized Controlled TrialZijia Liu, Tian Qiu, Lijian Pei, et al.Frontiers in Surgery|November 16, 2020
Metastatic Patterns of Mediastinal Lymph Nodes in Small-Size Non-small Cell Lung Cancer (T1b)Yijun Wu, Chang Han, Liang Gong, et al.Annals of Palliative Medicine|November 13, 2020
Neoadjuvant immunotherapy plus chemotherapy achieved pathologic complete response in stage IIIB lung adenocarcinoma harbored EGFR G779F: a case reportYadong Wang, Xiaoying Yang, Xu Tian, et al.Pageof 20